Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 2, 2015, Pages 316-321

  Higgins, Peter D R ^a   Skup, Martha ^b   Mulani, Parvez M ^b   Lin, Jay ^c   Chao, Jingdong ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ABBVIE INC   (United States)

^c Novosys Health   (United States)

Author keywords

CD; IBD; Intestinal inflammation; Risk factor; Ulcerative colitis

Indexed keywords

ADALIMUMAB; BIOLOGICAL PRODUCT; CERTOLIZUMAB PEGOL; CORTICOSTEROID; INFLIXIMAB; NATALIZUMAB;

ADULT; ARTICLE; BIOLOGICAL THERAPY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; INFLAMMATORY BOWEL DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRESCRIPTION; RETROSPECTIVE STUDY; VENOUS THROMBOEMBOLISM; ADOLESCENT; ADVERSE EFFECTS; AGED; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; RISK ASSESSMENT; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL THERAPY; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84927626907     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.07.017     Document Type: Article

References (27)

1. Murthy S.K., Nguyen G.C. Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol 2011, 106:713-718.
2. Nguyen G.C., Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008, 103:2272-2280.
3. Novacek G., Weltermann A., Sobala A., et al. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology 2010, 139:779-787.
4. Scaldaferri F., Lancellotti S., Pizzoferrato M., et al. Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. World J Gastroenterol 2011, 17:594-608.
5. Bernstein C.N., Sargent M., Vos H.L., et al. Mutations in clotting factors and inflammatory bowel disease. Am J Gastroenterol 2007, 102:338-343.
6. Yilmaz S., Bayan K., Tüzün Y., et al. Acomprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey. JThromb Thrombolysis 2006, 22:205-212.
7. Solem C.A., Loftus E.V., Tremaine W.J., et al. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004, 99:97-101.
8. Papa A., Danese S., Grillo A., et al. Review article: inherited thrombophilia in inflammatory bowel disease. Am J Gastroenterol 2003, 98:1247-1251.
9. Saibeni S., Vecchi M., Faioni E.M., et al. Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease. Dig Liver Dis 2003, 35:32-36.
10. Guédon C., Le Cam-Duchez V., Lalaude O., et al. Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease. Am J Gastroenterol 2001, 96:1448-1454.
11. Turri D., Rosselli M., Simioni P., et al. Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area. Dig Liver Dis 2001, 33:559-562.
12. Vecchi M., Sacchi E., Saibeni S., et al. Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci 2000, 45:1465-1469.
13. Sundaram K.K., Cotton R., Hart P., et al. Laboratory findings associated with thrombophilia are not more common in inflammatory bowel disease. Clin Lab Haematol 2000, 22:243-245.
14. Helio T., Wartiovaara U., Halme L., et al. Arg506Gln factor V mutation and Val34Leu factor XIII polymorphism in Finnish patients with inflammatory bowel disease. Scand J Gastroenterol 1999, 34:170-174.
15. Jackson L.M., O'Gorman P.J., O'Connell J., et al. Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. QJM 1997, 90:183-188.
16. Grainge M.J., West J., Card T.R. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010, 375:657-663.
17. Canonico M., Plu-Bureau G., Lowe G.D., et al. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 2008, 336:1227-1231.
18. Olié V., Canonico M., Scarabin P.Y. Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women. Curr Opin Hematol 2010, 17:457-463.
19. Herrinton L.J., Liu L., Lafata J.E., et al. Disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis 2007, 13:451-461.
20. Sewell J.L., Inadomi J.M., Yee H.F. Race and inflammatory bowel disease in an urban healthcare system. Dig Dis Sci 2010, 55:3479-3487.
21. Bernstein C.N., Wajda A., Blanchard J.F. The clustering of otherchronic inflammatory diseases in inflammatory disease: a population-based study. Gastroenterology 2005, 129:827-836.
22. Charlson M.E., Pompei P., Ales K.L., et al. Anew method of classifying prognostic comorbidity in longitudinal studies: development and validation. JChronic Dis 1987, 40:373-383.
23. Huerta C., Johansson S., Wallander M.A., et al. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 2007, 167:935-943.
24. Jess T., Gamborg M., Munkholm P., et al. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol 2007, 102:609-617.
25. Danese S., Papa A., Saibeni S., et al. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol 2007, 102:174-186.
26. Miehsler W., Reinisch W., Valic E., et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?. Gut 2004, 53:542-548.
27. Bernstein C.N., Blanchard J.F., Houston D.S., et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001, 85:430-434.